{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=F18-AV-45&page=2", "query": { "intervention": "F18-AV-45", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=F18-AV-45&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-24T05:04:10.198Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00857532", "title": "Florbetapir F 18 PET Imaging of Beta-amyloid in Parkinson's Disease Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Parkinson's Disease" ], "interventions": [ { "name": "florbetapir F 18", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Avid Radiopharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 31, "start_date": "2009-01", "completion_date": "2011-11", "has_results": true, "last_update_posted_date": "2013-03-11", "last_synced_at": "2026-09-24T05:04:10.198Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00857532" }, { "nct_id": "NCT02266563", "title": "Amyloid and Tauopathy PET Imaging in Acute and Chronic Traumatic Brain Injury", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Traumatic Brain Injury", "Chronic Traumatic Encephalopathy", "Mild Cognitive Impairment" ], "interventions": [ { "name": "Amyvid PET Scan", "type": "DRUG" }, { "name": "T807 PET scan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Samuel Gandy", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": "85 Years", "sex": "MALE", "summary": "40 Years to 85 Years · Male only" }, "enrollment_count": 46, "start_date": "2015-01", "completion_date": "2017-12-21", "has_results": false, "last_update_posted_date": "2019-05-02", "last_synced_at": "2026-09-24T05:04:10.198Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02266563" }, { "nct_id": "NCT00702143", "title": "A Phase II Trial of 18F-AV-45 Positron Emission Tomography (PET) Imaging in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alzheimer's Disease", "Mild Cognitive Impairment" ], "interventions": [ { "name": "florbetapir F 18", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Avid Radiopharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 184, "start_date": "2008-06", "completion_date": "2008-12", "has_results": true, "last_update_posted_date": "2012-05-10", "last_synced_at": "2026-09-24T05:04:10.198Z", "location_count": 15, "location_summary": "Phoenix, Arizona • Scottsdale, Arizona • Sun City, Arizona + 12 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Costa Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00702143" }, { "nct_id": "NCT02051790", "title": "Evaluation of Reader Training Processes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Alzheimer's Disease" ], "interventions": [ { "name": "florbetapir F 18", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Avid Radiopharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 241, "start_date": "2014-03", "completion_date": "2014-08", "has_results": true, "last_update_posted_date": "2015-09-28", "last_synced_at": "2026-09-24T05:04:10.198Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02051790" }, { "nct_id": "NCT01703702", "title": "Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive Decline", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Alzheimer's Disease" ], "interventions": [ { "name": "florbetapir (18F)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Avid Radiopharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "50 Years to 90 Years" }, "enrollment_count": 641, "start_date": "2012-10", "completion_date": "2015-04", "has_results": true, "last_update_posted_date": "2016-08-17", "last_synced_at": "2026-09-24T05:04:10.198Z", "location_count": 21, "location_summary": "Phoenix, Arizona • Scottsdale, Arizona • Sun City, Arizona + 15 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Clearwater", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01703702" }, { "nct_id": "NCT01400425", "title": "Potential of Florbetapir F 18 PET to Inform Clinical Diagnosis and Management of Patients With Progressive Cognitive Decline", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Progressive Cognitive Decline" ], "interventions": [ { "name": "florbetapir F 18", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Avid Radiopharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 239, "start_date": "2011-07", "completion_date": "2012-07", "has_results": true, "last_update_posted_date": "2013-03-29", "last_synced_at": "2026-09-24T05:04:10.198Z", "location_count": 18, "location_summary": "Phoenix, Arizona • Sun City, Arizona • San Francisco, California + 14 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "San Francisco", "state": "California" }, { "city": "Boulder", "state": "Colorado" }, { "city": "Boynton Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01400425" }, { "nct_id": "NCT03019757", "title": "Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Alzheimer's Disease", "Lewy Body Dementia", "Parkinson's Disease" ], "interventions": [ { "name": "DaTscan", "type": "RADIATION" }, { "name": "F18-AV-45", "type": "RADIATION" }, { "name": "FDG-PET", "type": "RADIATION" }, { "name": "APOE genotype", "type": "GENETIC" }, { "name": "Polysomnogram", "type": "PROCEDURE" }, { "name": "Clinical Assessment", "type": "BEHAVIORAL" } ], "intervention_types": [ "RADIATION", "GENETIC", "PROCEDURE", "BEHAVIORAL" ], "sponsor": "Douglas Scharre", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 76, "start_date": "2018-08-30", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2025-03-30", "last_synced_at": "2026-09-24T05:04:10.198Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03019757" }, { "nct_id": "NCT02120664", "title": "Florbetapir Calibration to the Centiloid Scale", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Alzheimer's Disease" ], "interventions": [ { "name": "Florbetapir (18F)", "type": "DRUG" }, { "name": "11C-PiB", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Avid Radiopharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 35, "start_date": "2014-04", "completion_date": "2015-09", "has_results": true, "last_update_posted_date": "2017-03-09", "last_synced_at": "2026-09-24T05:04:10.198Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02120664" }, { "nct_id": "NCT00855868", "title": "Ability Of ([18F]-AV-45) PET Scan to Distinguish Alzheimer's Disease Subjects From Cognitively Normal Individuals", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alzheimer's Disease" ], "interventions": [ { "name": "florbetapir F 18", "type": "DRUG" }, { "name": "[11C]-PIB", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Avid Radiopharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "55 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "55 Years to 90 Years" }, "enrollment_count": 28, "start_date": "2009-03", "completion_date": "2011-01", "has_results": true, "last_update_posted_date": "2012-07-26", "last_synced_at": "2026-09-24T05:04:10.198Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00855868" }, { "nct_id": "NCT00857415", "title": "Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the Brain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Alzheimer's Disease" ], "interventions": [ { "name": "florbetapir F 18", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Avid Radiopharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 226, "start_date": "2008-12", "completion_date": "2010-05", "has_results": true, "last_update_posted_date": "2012-05-22", "last_synced_at": "2026-09-24T05:04:10.198Z", "location_count": 25, "location_summary": "Phoenix, Arizona • Scottsdale, Arizona • Sun City, Arizona + 22 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Irvine", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00857415" } ] }